Wockhardt Share Surges 19% as USFDA Accepts New Drug Filing
Wockhardt share soared by 19% on Tuesday as the US Food and Drug Administration (USFDA) accepted the company’s new drug application (NDA) for its breakthrough antibiotic, Zaynich. This development marks a significant milestone for Wockhardt, one of India’s leading pharmaceutical companies, highlighting its growing presence in the global market. The announcement immediately triggered a surge…